|
⚲
|
| Keyboard |
| Carole Nuechterlein | |
|---|---|
| Firm | |
| Address | c/o Aligos Therapeutics, Inc One Corporate Dr, 2nd Floor South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aligos Therapeutics Inc | 021-539576 | Director | 105.0 M of 105.0 M |
||
| Aligos Therapeutics Inc | 021-496669 | Director | 92.2 M of 92.2 M |
||
| Entrada Therapeutics Inc | 021-395485 | Director | 116.2 M of 116.2 M |
||
| CIVI Biopharma Holdings Inc | 021-384757 | Director | 27.5 M of 27.5 M |
||
| Maculogix Inc | 021-384750 | Director | 22.0 M of 22.0 M |
||
| Maculogix Inc | 021-361598 | Director | 16.0 M of 17.0 M |
||
| Lysosomal Therapeutics Inc | 021-352903 | Director | 1.0 M of 3.0 M |
||
| Maculogix Inc | 021-334757 | Director | 37.7 M of 42.9 M |
||
| CIVI Biopharma Holdings Inc | 021-312966 | Director | 49.0 M of 49.0 M |
||
| Lysosomal Therapeutics Inc | 021-272003 | Director | 6.0 M of 6.0 M |
||
| Tioma Therapeutics Inc | 021-245292 | Director | 33.2 M of 86.3 M |
||